CN Patent

CN101027292A — 化合物、含有它们的组合物、其制备方法及其用途

Assigned to AstraZeneca AB · Expires 2007-08-29 · 19y expired

What this patent protects

本发明制备了式I化合物或其药学可接受的盐，其中G、R 1 、R 2 、R 3 、R 4 和R 5 是如说明书所定义的，以及盐和包括这些化合物的药物组合物。它们可用于治疗，特别是用于疼痛控制。

USPTO Abstract

本发明制备了式I化合物或其药学可接受的盐，其中G、R 1 、R 2 、R 3 、R 4 和R 5 是如说明书所定义的，以及盐和包括这些化合物的药物组合物。它们可用于治疗，特别是用于疼痛控制。

Drugs covered by this patent

Patent Metadata

Patent number
CN101027292A
Jurisdiction
CN
Classification
—
Expires
2007-08-29
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.